Back to Search
Start Over
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
- Source :
- Annals of Medicine, Vol 54, Iss 1, Pp 1562-1569 (2022)
- Publication Year :
- 2022
- Publisher :
- Taylor & Francis Group, 2022.
-
Abstract
- Purpose Skeletal muscle index (SMI) is a promising predictor of clinical outcomes in patients with malignant diseases. As a simpler surrogate of sarcopenia-psoas muscle index (PMI), its predict value for overall survival (OS) after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) has not been reported. To determine if changes in the PMI predicted OS in individuals with HCC treated with TACE.Patients and Methods A retrospective analysis was performed in HCC patients treated with TACE between January 2018 and March 2019. The survival curve according to PMI was estimated by the Kaplan–Meier method and then compared by the log-rank test. Cox proportional hazards models were conducted to identify the prognostic factors for OS. Furthermore, the predictive abilities of PMI and SMI were compared by using Harrell’s concordance index (C-index).Results Two hundred and twenty-eight patients (175 men, mean age 59 ± 11 years) were analysed. The OS was less in patients with low PMI than those with high PMI (median OS: 16.9 vs. 38.5 months, p
Details
- Language :
- English
- ISSN :
- 07853890 and 13652060
- Volume :
- 54
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Annals of Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b97f3bd23e214ffe95bcbb404d79cf79
- Document Type :
- article
- Full Text :
- https://doi.org/10.1080/07853890.2022.2081872